MAM
PMVP icon

Marquette Asset Management’s PMV Pharmaceuticals PMVP Stock Holding History

Marquette Asset Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-64,009
Closed -$96.7K – 189
2024
Q4 		$96.7K Hold
64,009
– – 0.02% 125
2024
Q3 		$95.4K Hold
64,009
– – 0.02% 136
2024
Q2 		$104K Hold
64,009
– – 0.02% 105
2024
Q1 		$109K Buy
+64,009
New +$120K 0.02% 112

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marquette Asset Management's PMVP Position: Q1 2025 in Review

Marquette Asset Management sold out of PMV Pharmaceuticals (PMVP) in Q1 2025, closing a stake of 64,009 shares — an estimated $96.7K sold.

Marquette Asset Management first reported a position in PMVP in Q1 2024 and held it in 4 quarters. The position peaked at $109K in Q1 2024. 55 funds tracked by Wall St. Rank hold PMVP as of Q1 2025.

  • Marquette Asset Management reported no remaining PMV Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Marquette Asset Management sold 64,009 PMV Pharmaceuticals shares in Q1 2025, an estimated $96.7K.
  • Marquette Asset Management first reported a position in PMV Pharmaceuticals in Q1 2024 and held it in 4 quarters.
  • Marquette Asset Management's PMV Pharmaceuticals position peaked at $109K in Q1 2024.
  • 55 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2025.

Based on Marquette Asset Management's 13F filing for Q1 2025, filed 9 Apr 2025.